Drospirenone is a progestin medication which is used in birth control pills to prevent pregnancy and in menopausal hormone therapy, among other uses. It is available only in combination with an estrogen and is not available alone. The medication is taken by mouth.

Sterling holds Certificate of Suitability n. R0-CEP 2009-193-Rev 00 issued by Quality of Medicines & HealthCare (EDQM) on 26/08/2010.

US DMF was submitted to FDA on 27/06/2008 and the following number was assigned n. 21733.

Drug product containing Sterling’s Drospirenone is commercialized in the USA and in other Countries.